Article

hamodia.com on 2020-08-14 11:07

China Sinopharm’s Potential COVID-19 Vaccine Triggers Antibodies in Clinical Trials

A coronavirus vaccine candidate developed by a unit of China National Pharmaceutical Group (Sinopharm) appeared to be safe and triggered antibody-based imm

Related news